Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Monday, September 11, 2023

Boston Scientific Valuation

 


Boston Scientific Corporation, the biomedical/biotechnology engineering firm is overvalued according to Wolfteam Ltd.

At 12.68 billion USD in annual revenue, growing at 6.68 % and net profit margin of 5.50 % Boston Scientific's intrinsic worth is 60 billion USD compared with Boston Scientific current market capitalization of 78.88 billion USD. In addition, Boston scientific does not distribute dividend.

The market seems to have too optimistic revenue growth and profitability projections for Boston Scientific. According to Wolfteam Ltd.'s growth forecasts, profitability estimates and comparables analysis Boston Scientific is overvalued.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)